| Literature DB >> 34012604 |
Kefang Lai1, Jiaman Tang1, Wenzhi Zhan1, Hu Li1, Fang Yi1, Li Long1, Jianmeng Zhou1, Xiaomei Chen1, Lianrong Huang1, Zhangyu Sun1, Ziyu Jiang1, Yuehan Chen1, Hankun Lu1, Wei Luo1, Ruchong Chen1, Nanshan Zhong1.
Abstract
BACKGROUND: Chronic cough has many diverse causes, including common and uncommon causes. There are few comprehensive reports on rare causes of chronic cough. The purpose of this study is to determine the etiological distribution, clinical features, and diagnostic value of special examinations in patients with rare causes of chronic cough.Entities:
Keywords: Chronic cough; rare cause; special examination; spectrum
Year: 2021 PMID: 34012604 PMCID: PMC8107567 DOI: 10.21037/jtd-20-2671
Source DB: PubMed Journal: J Thorac Dis ISSN: 2072-1439 Impact factor: 2.895
Figure 1The spectrum and frequency of chronic cough.
The spectrum and frequency of rare causes of chronic cough based on anatomy
| Anatomy | Causes |
|---|---|
| Upper-airway (28, 1.6%) | OSAS (23, 9.79%), mucous cyst of salivary gland (1, 0.43%), laryngocarcinoma (1, 0.43%), VCD (2, 0.85%), laryngeal amyloidosis (1, 0.43%) |
| lower-airway (102, 5.7%) | PBB (44, 18.72%), DPB (31, 13.19%), FACC (4, 1.70%), bronchial tuberculosis (5, 2.13%), bronchial foreign body (2, 0.85%), broncholithiasis (1, 0.43%), BACC (1, 0.43%), Kartagener syndrome (1, 0.43%), relapsing polychondritis (8, 3.40%), sarcoidosis (1, 0.43%), postoperative cough (4, 1.70%) |
| Lung (27, 1.5%) | ILD (23, 9.79%), atypical pneumoconiosis (2, 0.85%), COP (2, 0.85%) |
| Other systems (78, 4.4%) | Somatic cough syndrome (37, 15.74%), hyperventilation syndrome (15, 6.38%), ACEI-induced cough (8, 3.40%), arrhythmia (5, 2.13%), HIVD (3, 1.28%), goiter (1, 0.43%), occupational cough (2, 0.85%), styloid process syndrome (1, 0.43%), HES (3,1.28%), catamenial cough (1, 0.43%), LCH (1,0.43%), cardiogenic cough (1,0.43%) |
Data are presented as (cases, percentage of total cases of chronic cough). OSAS, obstructive sleep apnea syndrome; VCD, vocal cord disfunction; PBB, protracted bacterial bronchitis; DPB, diffuse panbronchiolitis; FACC, fungus-associated cough; BACC, bronchial adenoid cystic carcinoma; ILD, interstitial lung disease; COP, cryptogenic organizing pneumonia; ACEI, angiotensin-converting enzyme inhibitor; HIVD, herniated cervical intervertebral disc; HES, hypereosinophilic syndrome; LCH, Langerhans cell histiocytosis.
Figure 2The spectrum and frequency of rare causes. PBB, protracted bacterial bronchitis; SCS, somatic cough syndrome; DPB, diffuse pan bronchiolitis; OSAS, obstructive sleep apnea syndrome; ILD, interstitial lung disease.
Values of special examinations in diagnosing rare causes in the cohort
| Examination | Rare causes (cases) | Total cases, (%) |
|---|---|---|
| Bronchoscopy/nasopharyngoscopy | Relapsing polychondritis (3 cases), Bronchial tuberculosis (5 cases), Bronchial foreign body (2 cases), Mucous cyst of salivary gland (1 case), Broncholithiasis (1 case), TACC (1 case), Pneumoconiosis (1 case), COP (2 cases), Laryngocarcinoma (1 case), VCD (2 cases), Laryngeal amyloidosis (1 case), PBB (6 cases), Sarcoidosis (1 case), DPB (7 cases), ILD (6 cases), HES (2 cases), LCH (1 case), BACC (1 case) | 44/235 (18.7%) |
| HRCT | DPB (31 cases), ILD (23 cases), Relapsing polychondritis (8 cases), COP (2 cases), PPB (9 cases), Bronchial tuberculosis (5 cases), Bronchial foreign body (2 cases), TACC (1 case), Broncholithiasis (1 case), LCH (1 case), Atypical pneumoconiosis (2 cases), Kartagener syndrome (1 case), HES (3 cases), BACC (1 case) | 90/235 (38.3%) |
| Sinus CT | DPB (31 cases), OSAS (1 case) | 32/235 (13.6%) |
| Pulmonary diffusing capacity | ILD (14 cases), DPB (3 cases), TACC (1 case), LCH (1 case), sarcoidosis (1 case), COP (1 case) | 21/235 (8.9%) |
OSAS, obstructive sleep apnea syndrome; VCD, vocal cord disfunction; PBB, protracted bacterial bronchitis; DPB, diffuse pan bronchiolitis; FACC, fungus-associated cough; BACC, bronchial adenoid cystic carcinoma; ILD, interstitial lung disease; COP, cryptogenic organizing pneumonia; ACEI, angiotensin-converting enzyme inhibitor; HES, hypereosinophilic syndrome; LCH, Langerhans cell histiocytosis.